Plant-based ointment for recurring nosebleeds
Part of Ear, nose & throat, Lungs & breathing clinical trials.
This trial tests whether a plant-based ointment (B-sitosterol) applied inside the nose works better than a standard petroleum jelly to reduce recurring nosebleeds. If you have frequent nosebleeds without an obvious cause, this treatment might help you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had at least 2 nosebleeds in the last month.
- Your nosebleeds are not caused by an injury or recent surgery.
- You do not have a bleeding disorder or take blood-thinning medication.
- You are not allergic to the study ointments (B-sitosterol or petroleum jelly).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for nosebleeds that start in the front of the nose. It tests whether a gel made from hyaluronic acid works better than petroleum jelly to stop the bleeding and help the area heal.
This trial tests a new topical gel (TOR-582) applied inside the nose to reduce nosebleeds in people with HHT. It may help by targeting the abnormal blood vessels that cause frequent bleeding.
This study looks at different management strategies for severe nosebleeds when the initial packing method has not worked for over 48 hours. It also measures the cost/benefit of these approaches to help improve care.
This study tests whether a natural orange peel extract can help stop nosebleeds in children. It may offer a gentle, non-chemical option for managing this common problem.
This study tests whether a special nasal packing (a soft material placed in the nose) stops nosebleeds better than the usual treatment. It may help people who come to the emergency room with a nosebleed that won't stop.
This study compares two ways to stop frequent nosebleeds in children who have not been helped by simpler treatments. Children will get one of two minor procedures to seal the tiny blood vessel in the nose that keeps bleeding, and the study will see which works better and is safer.
Hear when a new Epistaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.